These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19264544)

  • 21. Evaluation of human papillomavirus DNA detection in samples obtained for routine Chlamydia trachomatis screening.
    Söderlund-Strand A; Wikström A; Dillner J
    J Clin Virol; 2015 Mar; 64():88-91. PubMed ID: 25728085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.
    Hesselink AT; Bulkmans NW; Berkhof J; Lorincz AT; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2006 Oct; 44(10):3680-5. PubMed ID: 17021097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems.
    Payan C; Ducancelle A; Aboubaker MH; Caer J; Tapia M; Chauvin A; Peyronnet D; Le Hen E; Arab Z; Legrand MC; Tran A; Postec E; Tourmen F; Avenel M; Malbois C; De Brux MA; Descamps P; Lunel F
    J Clin Microbiol; 2007 Mar; 45(3):897-901. PubMed ID: 17229868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.
    Heard I; Cuschieri K; Geraets DT; Quint W; Arbyn M
    J Clin Virol; 2016 Aug; 81():6-11. PubMed ID: 27262102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types.
    Jacobs MV; Walboomers JM; Snijders PJ; Voorhorst FJ; Verheijen RH; Fransen-Daalmeijer N; Meijer CJ
    Int J Cancer; 2000 Jul; 87(2):221-7. PubMed ID: 10861478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
    Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
    Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer.
    Walboomers JM; de Roda Husman AM; Snijders PJ; Stel HV; Risse EK; Helmerhorst TJ; Voorhorst FJ; Meijer CJ
    J Clin Pathol; 1995 Aug; 48(8):728-32. PubMed ID: 7560199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid real time PCR to distinguish between high risk human papillomavirus types 16 and 18.
    Cubie HA; Seagar AL; McGoogan E; Whitehead J; Brass A; Arends MJ; Whitley MW
    Mol Pathol; 2001 Feb; 54(1):24-9. PubMed ID: 11212885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCR-RFLP assay as an option for primary HPV test.
    Golfetto L; Alves EV; Martins TR; Sincero TCM; Castro JBS; Dannebrock C; Oliveira JG; Levi JE; Onofre ASC; Bazzo ML
    Braz J Med Biol Res; 2018 Mar; 51(5):e7098. PubMed ID: 29590262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Human papilloma virus (HPV) testing for cervical carcinoma screening].
    Nocon M; Roll S; Mittendorf T; von der Schulenburg JM; Willich SN
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(2):138-42. PubMed ID: 20441022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Accuracy of oncotic cytology for HPV infection diagnosis on the cervix uteri of HIV-infected women].
    de Faria IM; Melo VH; de Castro LP; de Faria FM; Carvalho Nde O; de Araújo AC; de Oliveira HC
    Rev Bras Ginecol Obstet; 2008 Sep; 30(9):437-44. PubMed ID: 19142529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitfalls of commercially available HPV tests in HPV68a detection.
    Jaworek H; Kubanova K; Koudelakova V; Slavkovsky R; Drabek J; Hajduch M
    PLoS One; 2019; 14(8):e0220373. PubMed ID: 31381580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cardiff Cervical Cytology Study: prevalence of cytological grades and initial histological findings.
    Evans DM; Hibbard BM; Jones JM; Sweetnam P
    Br Med J (Clin Res Ed); 1981 Feb; 282(6265):689-91. PubMed ID: 6781617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newly developed liquid-based cytology. TACAS™: cytological appearance and HPV testing using liquid-based sample.
    Kubushiro K; Taoka H; Sakurai N; Yamamoto Y; Kurasaki A; Asakawa Y; Iwahara M; Takahashi K
    Hum Cell; 2011 Sep; 24(3):115-20. PubMed ID: 21656277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus.
    Evans MF; Adamson CS; Simmons-Arnold L; Cooper K
    BMC Clin Pathol; 2005 Nov; 5():10. PubMed ID: 16288661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes.
    van den Brule AJ; Pol R; Fransen-Daalmeijer N; Schouls LM; Meijer CJ; Snijders PJ
    J Clin Microbiol; 2002 Mar; 40(3):779-87. PubMed ID: 11880393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.